The CE marked Rapid MiniLab is fully automatic with all processes carried out onboard by the MiniLab’s patented miniature robotic arm. The MiniLab System fully automates the PCR process from raw sample to result system, reducing the risk of human error, negating human variance, while improving reliability and repeatability. The MiniLab was engineered to be...
Author: admin
adminPost
Rapid Diagnostics ML Limited have developed a saliva sample Real-Time PCR Point of Care test for the accurate detection of COVID-1
Rapid Diagnostics ML Limited have developed a saliva sample Real-Time PCR Point of Care test for the accurate detection of COVID-19. “In the last few weeks we have succeeded in developing a new saliva sample Covid-19 test. This is a great alternative to the invasive, and sometimes painful, deep nasal (mucus) sample and throat (sputum)...
adminPost
Rapid Diagnostics Resurrects Multiplex MiniLab Platform, Targets TB POC Test
LEO O’CONNOR DECEMBER 18, 2019 NEW YORK – After years developing technology to do multiplex testing for infectious diseases, Enigma Diagnostics shuttered about two years ago without much fanfare. But thanks to a former investor in the company, Enigma’s technology may live on. The investor, Robert Clink, had invested a large part of the £140 million...
adminPost
Regulatory Approval
The MiniLab and the Respiratory Assay (ML Influenza A/B RSV test, part ML-CA-0001) received the EC Declaration of Conformity in July 2016
adminPost
American Society for Microbiology
Journal of Clinical Microbiology. January 2016 Volume 54 Number 1
(Available for Download)